en

PRODUCT DETAIL

Cablivi 10 mg prášok a rozpúšťadlo na injekčný roztok

Code 2716D
MA number EU/1/18/1305/003
Product Form: plv iol 7(7x1)x10 mg + 7(7x1)x1 ml solv. (liek.inj.skl. + striek.inj.napl.skl.-multibal.)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU Orphan
Therapeutic Class: 16 - ANTICOAGULANTIA (FIBRINOLYTICA, ANTIFIBRINOL.)
ATC:
B BLOOD AND BLOOD FORMING ORGANS
B01 ANTITHROMBOTIC AGENTS
B01A ANTITHROMBOTIC AGENTS
B01AX Other antithrombotic agents
B01AX07 Caplacizumab
Shelf life: 48
Container: glass vial
Route of admin.: Subcutaneous and intravenous use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 8(3) application - new active substance
MA issued: 22.10.2018
Validity: 31.08.2023
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 24.10.2019
eu-flag.png sk-flag.png